April 2017
Volume 12 Issue 4 |
|
|
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
|
|
API Synthesis and Manufacturing
Researchers continue efforts to overcome challenges of effective oral delivery of biologic drugs.
/ read more /
The agency sent a warning letter to Badrivishal Chemicals & Pharmaceuticals detailing several CGMP violations.
/ read more /
|
|
|
ADVERTISEMENT
Pharmaceutical Technology's PharmaMarketplace
Your Connection to Global Pharmaceutical Manufacturing Suppliers
Check it out today! |
|
|
|
The agency sent a warning letter to Chongqing Pharma Research Institute Co., Ltd. citing data integrity violations.
/ read more /
RSSL has added new equipment for measuring the surface area of powder particles, which is important for determining the performance of excipients and APIs.
/ read more /
Excipient manufacturer adds three tablet binding and disintegration products.
/ read more /
|
|
|
ADVERTISEMENT
The research and intelligence tool every bio/pharmaceutical sourcing executive should have.
PharmSource STRATEGIC ADVANTAGE is the online intelligence service for companies that buy or sell bio/pharmaceutical contract manufacturing and development services. It provides executives with accurate data and deep insights that help them make highly informed strategic decisions.
Learn more about PharmSource STRATEGIC ADVANTAGE today. |
|
|
|
Outsourcing Update
What are the pros, cons, and practicalities of moving pharma manufacturing back to the US?
/ read more /
|
|
|
In the Lab
Informatics platforms and automation solutions may support efforts to improve data integrity practices.
/ read more /
|
|
|
Supply Chain Update
In a pilot program, Johnson & Johnson Supply Chain and AmerisourceBergen demonstrated how data can be transferred between two partners.
/ read more /
|
|
|
Contract Services Update
The newly installed Harro Höfliger encapsulation unit expands Capsugel's clinical- and commercial-scale capacity for dry powder inhalation projects.
/ read more /
Permira will acquire LSNE, a CDMO for the pharmaceutical and medical device markets.
/ read more /
The company has secured an additional facility in Hampton, Middlesex, as part of a project to expand its UK-based operations by 15% in 2017.
/ read more /
The company has invested in a new pharmaceutical chemistry and microbiology facility in Scotland.
/ read more /
Caladrius is selling the remaining percentage of the subsidiary to focus on cell therapy development.
/ read more /
Manufacturing will be carried out at the Pfizer Newbridge, Ireland, facility, which is now part of Pfizer CentreOne's contract manufacturing network.
/ read more /
|
|
|
|
|